News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SMITH IAN F
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Exercised 15,569 restricted stock units
@ $0 |
|
| 07/06/2023 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Exercised 15,570 restricted stock units
@ $0 |
|
| 06/08/2023 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Exercised 15,569 restricted stock units
@ $0
Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 01/05/2023 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Exercised 1,620 restricted stock units
@ $0
Exercised 70,796 options to buy
@ $5.62, valued at
$397.9k
Granted 62,278 restricted stock units
@ $0 |
|
| 12/15/2022 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.47, valued at
$62.4k
|
|
| 12/05/2022 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 13,172 shares
@ $0 |
|
| 10/04/2022 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Exercised 24,312 restricted stock units
@ $0 |
|
| 09/13/2022 |
3/A
| SMITH IAN F (Director) has filed a Form 3/A on Foghorn Therapeutics Inc. |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| SMITH IAN F (Director) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 16,000 options to buy
@ $13.81, valued at
$221k
|
|
| 06/09/2022 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 51,000 options to buy
@ $0.625, valued at
$31.9k
|
|
| 04/05/2022 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Exercised 24,313 restricted stock units
@ $0 |
|
| 01/05/2022 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 194,500 options to buy
@ $1.78, valued at
$346.2k
Granted 97,250 restricted stock units
@ $0 |
|
| 06/24/2021 |
4
| SMITH IAN F (Director) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 12,530 options to buy
@ $10.24, valued at
$128.3k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| SMITH IAN F (Director) has filed a Form 4 on Foghorn Therapeutics Inc.|
Txns:
| Granted 25,060 options to buy
@ $11.5, valued at
$288.2k
|
|
| 04/29/2021 |
3
| SMITH IAN F (Director) has filed a Form 3 on Foghorn Therapeutics Inc. |
| 01/06/2021 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 389,000 options to buy
@ $7.84, valued at
$3M
|
|
| 12/14/2020 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 270,270 shares
@ $3.7, valued at
$1000k
|
|
| 06/18/2020 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 200,000 options to buy
@ $3.03, valued at
$606k
|
|
| 04/16/2020 |
4
| SMITH IAN F (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 40,000 options to buy
@ $2.49, valued at
$99.6k
|
|
| 04/16/2020 |
3
| SMITH IAN F (Director) has filed a Form 3 on Solid Biosciences Inc. |
| 07/03/2018 |
4
| SMITH IAN F (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 4,741 shares
@ $165.22, valued at
$783.3k
Sold 18,634 shares
@ $166.57, valued at
$3.1M
Exercised 23,375 options to buy
@ $131.89, valued at
$3.1M
|
|
| 06/29/2018 |
4
| SMITH IAN F (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Granted 15,000 options to buy
@ $28.15, valued at
$422.3k
|
|
| 06/26/2018 |
4
| SMITH IAN F (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 4,250 shares
@ $160, valued at
$680k
Exercised 4,250 options to buy
@ $109.14, valued at
$463.8k
|
|
| 06/19/2018 |
4
| SMITH IAN F (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 25,000 shares
@ $31.4227, valued at
$785.6k
Exercised 10,000 options to buy
@ $25.45, valued at
$254.5k
Exercised 15,000 options to buy
@ $13.8, valued at
$207k
|
|
| 06/14/2018 |
4
| SMITH IAN F (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 22,857 shares
@ $1.75, valued at
$40k
Granted 20,000 options to buy
@ $1.75, valued at
$35k
Granted 4,000 options to buy
@ $1.75, valued at
$7k
|
|
| 05/16/2018 |
4
| SMITH IAN F (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 217 shares
@ $155.78, valued at
$33.8k
|
|
| 05/04/2018 |
4
| SMITH IAN F (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC|
Txns:
| Sold 3,677 shares
@ $23.4641, valued at
$86.3k
Sold 6,323 shares
@ $23.8648, valued at
$150.9k
Exercised 10,000 options to buy
@ $20.16, valued at
$201.6k
|
|
| 02/08/2018 |
4
| SMITH IAN F (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 15,170 shares
@ $0
Granted 8,437 shares
@ $0
Granted 19,566 options to buy
@ $155.57, valued at
$3M
|
|
| 01/17/2018 |
4
| SMITH IAN F (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 825 shares
@ $155.8, valued at
$128.5k
Sold 400 shares
@ $157.02, valued at
$62.8k
Sold 400 shares
@ $158.11, valued at
$63.2k
Sold 500 shares
@ $159.29, valued at
$79.6k
Exercised 2,125 options to buy
@ $96.87, valued at
$205.8k
|
|
| 11/17/2017 |
4
| SMITH IAN F (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 7 shares
@ $147.29, valued at
$1k
|
|
| 11/07/2017 |
4
| SMITH IAN F (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 2,155 shares
@ $150, valued at
$323.3k
Sold 4,250 shares
@ $150, valued at
$637.5k
Exercised 2,155 options to buy
@ $91.05, valued at
$196.2k
Exercised 4,250 options to buy
@ $77.31, valued at
$328.6k
|
|
| 10/31/2017 |
4
| SMITH IAN F (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 1,700 shares
@ $142.4, valued at
$242.1k
Sold 5,200 shares
@ $143.47, valued at
$746k
Sold 32,945 shares
@ $144.47, valued at
$4.8M
Sold 22,464 shares
@ $145.26, valued at
$3.3M
Sold 5,200 shares
@ $146.39, valued at
$761.2k
Sold 3,500 shares
@ $147.4, valued at
$515.9k
Sold 3,791 shares
@ $148.26, valued at
$562.1k
Sold 200 shares
@ $149.34, valued at
$29.9k
|
|
|
|
|